NanoString makes instruments and services to profile genes and proteins from tissue samples. The biotech company lost a patent court fight to 10x Genomics (TXG +5.01%) that forces NanoString to quit ...

NanoString’s GeoMX Digital Spatial Profiler was at the heart of a patent lawsuit filed by 10x Genomics. (NanoString Image) Shares of Seattle-based publicly traded biotech company NanoString ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the launch of the nCounter® ...

SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research, today announced a strategic transaction to exclusively ...

Inclusion of Abcam validated antibodies in CosMx curated protein panel provides the first high-plex spatial multiomic solution at single-cell and subcellular resolution SEATTLE & CAMBRIDGE, United ...

Nanostring Technologies, a maker of life science research tools, said it has filed for Chapter 11 bankruptcy protection and is exploring strategic alternatives in connection with the proceedings, ...

NanoString Technologies, a provider of life science tools for research and molecular diagnostic products, has filed to raise $55 million through a secondary stock offering. The filing comes seven ...

SEATTLE--(BUSINESS WIRE)--NanoString Technologies, a leading provider of life sciences tools for discovery and translational research, announced today the line-up of researchers joining NanoString at ...

NanoString Technologies, joined by three of its subsidiaries, have filed for protection from creditors under Chapter 11 of the U.S. Bankruptcy Code, blaming the $31 million jury award assessed against ...

NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, and Abcam (AIM: ABC; NASDAQ: ABCM), a global life science company ...